MODULAR BACTERIOPHAGE T4 NANOPARTICLE PLATFORM ENABLES RAPID DESIGN OF DUAL COVID-19-FLU MUCOSAL VACCINES
Application
US20260083835A1
Kind: A1
Mar 26, 2026
Inventors
Venigalla B. Rao, Jingen Zhu
Abstract
A non-infections bacteriophage T4 nanoparticle vaccine composition includes a bacteriophage capsid and at least one antigen displayed on the surface of the capsid or packaged in its interior. The vaccine is administered intranasally and is free of an adjuvant. The antigen is selected from respiratory viruses including coronavirus and influenza.
CPC Classifications
A61K 39/145
A61K 9/0043
A61K 9/5184
A61K 9/5192
A61K 39/215
A61K 47/02
A61P 31/16
C07K 14/005
C12N 7/00
C12N 9/222
C12N 15/111
A61K 2039/5254
A61K 2039/5256
A61K 2039/543
A61K 2039/55555
A61K 2039/572
A61K 2039/575
A61K 2039/70
C07K 2319/40
C12N 2310/20
C12N 2760/16134
C12N 2770/20034
C12N 2795/10034
Filing Date
2025-09-24
Application No.
19337994